These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 794895)

  • 1. Emotional symptomatology in obese patients treated with fenfluramine and dextroamphetamine.
    Rickels K; Hesbacher P; Fisher E; Perloff MM; Rosenfeld H
    Psychol Med; 1976 Nov; 6(4):623-30. PubMed ID: 794895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenfluramine in the treatment of obesity.
    Stunkard A; Rickels K; Hesbacher P
    Lancet; 1973 Mar; 1(7802):503-5. PubMed ID: 4119946
    [No Abstract]   [Full Text] [Related]  

  • 3. Double-blind evaluation of reinforcing and anorectic actions of weight control medications. Interaction of pharmacological and behavioral treatments.
    Bigelow GE; Griffiths RR; Liebson I; Kaliszak JE
    Arch Gen Psychiatry; 1980 Oct; 37(10):1118-23. PubMed ID: 7000029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the acute effects of dextroamphetamine and fenfluramine in depression.
    Ward NG; Ang J; Pavinich G
    Biol Psychiatry; 1985 Oct; 20(10):1090-7. PubMed ID: 3899198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenfluramine and dextroamphetamine treatment of childhood hyperactivity. Clinical and biochemical findings.
    Donnelly M; Rapoport JL; Potter WZ; Oliver J; Keysor CS; Murphy DL
    Arch Gen Psychiatry; 1989 Mar; 46(3):205-12. PubMed ID: 2645848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin secretion and hydrocarbon tolerance in essential obesity in women (influence of fenfluramine, phenformin and D-amphetamine)].
    Cabezas Cerrato J; Catalán E; Vila T; Fernández-Cruz A
    Rev Clin Esp; 1973 May; 129(4):337-42. PubMed ID: 4720279
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulatory effects of fenfluramine in obese hypertensive patients.
    Mroczek WJ; Lee WR; Finnerty FA
    Curr Ther Res Clin Exp; 1974 Nov; 16(11):1197-202. PubMed ID: 4214654
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term efficacy of fenfluramine in treatment of obesity.
    Douglas JG; Gough J; Preston PG; Frazer I; Haslett C; Chalmers SR; Munro JF
    Lancet; 1983 Feb; 1(8321):384-6. PubMed ID: 6130379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic effects, and the composition of the tissue lost, in weight reduction by obese patients on treatment with fenfluramine.
    Durnin JV; Womersley J
    Br J Pharmacol; 1973 Sep; 49(1):115-20. PubMed ID: 4595485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of obesity with fenfluramine (Ponderal)].
    Persson I; Andersen UD; Deckert T
    Ugeskr Laeger; 1973 Sep; 135(36):1932-7. PubMed ID: 4590075
    [No Abstract]   [Full Text] [Related]  

  • 11. Fenfluramine, vitamin C and weight loss.
    Wilson CW; Foran K; Innes JA; Watson ML; Ford MJ; Stoddart ME; Munro JF
    Int J Obes; 1978; 2(4):463-5. PubMed ID: 370042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical observations on the treatment of obese patients with dexfenfluramine].
    Cairella M; Pisculli M; Petraroli AR; Riganelli S; Saracino A; Siani V
    Clin Ter; 1990 Jun; 133(5):289-97. PubMed ID: 2143712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of obesity with fenfluramine.
    Persson I; Andersen U; Deckert T
    Eur J Clin Pharmacol; 1973 Aug; 6(2):93-7. PubMed ID: 4588854
    [No Abstract]   [Full Text] [Related]  

  • 14. Fenfluramine (Ponderax) in the treatment of obese psychiatric out-patients.
    Gaind R
    Br J Psychiatry; 1969 Aug; 115(525):963-4. PubMed ID: 4895336
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of fenfluramine and placebo on obese Nigerians.
    Lewis EA; Adeleye GI; Ukponmwan OO
    Niger Med J; 1978; 8(2):104-7. PubMed ID: 347827
    [No Abstract]   [Full Text] [Related]  

  • 16. Fenfluramine in corticosteroid-induced obesity.
    Cameron DC; Kennedy WP; Samuel PD; Crompton GK
    Curr Med Res Opin; 1972; 1(3):153-8. PubMed ID: 4589709
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic self-medication as a context for drug abuse research.
    Bigelow GE; Liebson I; Kaliszak J; Griffiths RR
    NIDA Res Monogr; 1978 Jul; (20):44-58. PubMed ID: 101860
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of caloric restriction and fenfluramine on weight loss and personality profiles of patients with long standing obesity.
    Goldrick RB; Havenstein N; Whyte HM
    Aust N Z J Med; 1973 Apr; 3(2):131-41. PubMed ID: 4146050
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolonged weight loss with dexfenfluramine treatment in obese patients.
    Finer N; Craddock D; Lavielle R; Keen H
    Diabete Metab; 1987; 13(6):598-602. PubMed ID: 3329122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The therapeutic effect of Fenfluramine on body weight in overweight patients. A controlled clinical study].
    Haug E; Myklebust R
    Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2545-9. PubMed ID: 4589598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.